Poolbeg Pharma PLC (POLB.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.11M |
| Enterprise Value | 16.39M |
| P/E Ratio | -9.42 |
| PEG Ratio | -0.25 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.71 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -8.55 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.76 |
| Return On Equity | -0.71 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -59,000 |
| EBITDA | -6.36M |
| Net Income | -5.7M |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 4.82M |
| Total Cash/Share | 0.01 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 12.44 |
| Book Value Per Share | 0.01 |
Price History
| 52-Week Change | 104.17 |
| 52-Week High | 9.65 |
| 52-Week Low | 3.3 |
| Moving Average 50 Days | 8.05 |
| Moving Average 200 Days | 5.86 |
Statistics
| Average Volume | 2.92M |
| Shares Outstanding | 763.44M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
